— Know what they know.
Not Investment Advice

SRRK NASDAQ

Scholar Rock Holding Corporation
1W: +2.7% 1M: -13.5% 3M: -13.4% YTD: -0.7% 1Y: +43.2% 3Y: +456.1% 5Y: +60.3%
$42.49
+0.78 (+1.87%)
 
Weekly Expected Move ±6.0%
$36 $39 $41 $44 $46
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $5.2B mcap · 101M float · 1.66% daily turnover · Short 77% of daily vol
Credit Risk of going bust: lower than 68% of companies Debt: 3.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.18 (down 99.6%), Scholar Rock Holding Corporation would be worth roughly what it owes.
Total debt $203.8M against a stock market value of $5.08B.
Distance to default 7.29 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $98.1M (short-term plus half of long-term), stock volatility 54.1%; Altman Z'' -8.11. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
-$2M +14.4% ▲
Operating Income
-$385M -52.6% ▼
Net Income
-$378M -53.5% ▼
EPS (Diluted)
$-3.29 -33.2% ▼
EBITDA
-$369M -55.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$19M$33M$0$0$0
YoY Growth+22.2%+76.4%-100.0%+0.0%+0.0%
Cost of Revenue$108M$123M$3M$2M$2M
Gross Profit-$90M-$90M-$3M-$2M-$2M
Gross Margin-476.5%-270.7%———
R&D Expenses$108M$124M$119M$183M$207M
SG&A Expenses$40M$43M$49M$68M$176M
Operating Expenses$40M$45M$168M$250M$383M
Operating Income-$130M-$134M-$171M-$252M-$385M
Operating Margin-690.5%-404.8%———
Interest Expense$0$0$0$7M$7M
Income Before Tax-$132M-$135M-$166M-$246M-$378M
Tax Expense$0$0$0$0$0
Net Income-$132M-$135M-$166M-$246M-$378M
Net Margin-700.5%-405.2%———
EPS (Diluted)$-3.59$-2.21$-1.99$-2.47$-3.29
EBITDA-$127M-$129M-$163M-$238M-$369M
Shares Outstanding37M60M76M100M115M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms